Emergo Therapeutics, Inc. logo

Emergo Therapeutics, Inc.

Emergo Therapeutics is focused on developing drugs to modulate inflammatory cytokines and improve the functioning of the immune system in various potential indications, starting with infectious diseases. Emergo believes that inflammation caused by mast cells, a group of cells integral to innate immunity, is responsible for some of the most damaging symptoms and outcomes of seemingly unrelated diseases. A vast majority of these conditions are not treated with mast cell therapies, even though overwhelming evidence shows this would be therapeutically beneficial. Emergo’s therapeutic interventions are focused on reducing the production of inflammatory cytokines from mast cells.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://emergotherapeutics.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
6208 Fayetteville Road, Suite 104, NC, 27713
Durham
United States
Email
Contact Number
+1 984-377-5151

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/emergo-therapeutics” connections=”true” suffix=””]